<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115885">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01767168</url>
  </required_header>
  <id_info>
    <org_study_id>CER 10-218</org_study_id>
    <secondary_id>matped 10-054</secondary_id>
    <nct_id>NCT01767168</nct_id>
  </id_info>
  <brief_title>Study to Test the Value of a Pain Modulation Test in Predicting Persistent Postoperative Pain After Breast Cancer Surgery</brief_title>
  <acronym>PREDO</acronym>
  <official_title>Trial of Diagnostic Accuracy for the Prediction of Persistent Postoperative Pain After Breast Cancer Surgery Using a Conditioned Pain Modulation Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the hypothesis that a preoperative test of pain
      modulation predicts persistent pain 4 months after breast cancer surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>prevalence of pain at the site of surgery</measure>
    <time_frame>4 months postop</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Chronic Pain</condition>
  <condition>Acute Pain</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      venous blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        women scheduled for any type of breast cancer surgery in a university hospital breast
        cancer center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;=18 years

          -  American Society of Anesthesiology functional status I-III

          -  able to read and understand the information sheet and give informed consent

        Exclusion Criteria:

        none
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benno Rehberg-Klug, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Anesthesiology, HUG</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benno Rehberg-Klug, MD</last_name>
    <phone>+41 22 3823476</phone>
    <email>benno.rehberg-klug@hucge.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stanislas Mathivon, ISA</last_name>
    <phone>+41 22 37 27403</phone>
    <email>stanislas.mathivon@hcuge.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Genève</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benno Rehberg-Klug, MD</last_name>
      <email>benno.rehberg-klug@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Benno Rehberg-Klug, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 14, 2013</lastchanged_date>
  <firstreceived_date>January 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Benno Rehberg-Klug</investigator_full_name>
    <investigator_title>médecin adjoint agrégé</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
